A Sphingolipid Inhibitor Induces a Cytokinesis Arrest and Blocks Stage Differentiation in Giardia lamblia
- 1 February 2008
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 52 (2) , 563-569
Abstract
Sphingolipid biosynthesis pathways have recently emerged as a promising target for therapeutic intervention against pathogens, including parasites. A key step in the synthesis of complex sphingolipids is the glucosylation of ceramide, mediated by glucosylceramide (GlcCer) synthase, whose activity can be inhibited by PPMP (1-phenyl-2-palmitoylamino-3-morpholino-1-propanol). In this study, we investigated whether PPMP inhibits the proliferation and differentiation of the pathogenic parasite Giardia lamblia , the major cause of parasite-induced diarrhea worldwide. PPMP was found to block in vitro parasite replication in a dose-dependent manner, with a 50% inhibitory concentration of 3.5 μM. The inhibition of parasite replication was irreversible at 10 μM PPMP, a concentration that did not affect mammalian cell metabolism. Importantly, PPMP inhibited the completion of cell division at a specific stage in late cytokinesis. Microscopic analysis of cells incubated with PPMP revealed the aberrant accumulation of cellular membranes belonging to the endoplasmic reticulum network in the caudal area of the parasites. Finally, PPMP induced a 90% reduction in G. lamblia differentiation into cysts, the parasite stage responsible for the transmission of the disease. These results show that PPMP is a powerful inhibitor of G. lamblia in vitro and that as-yet-uncharacterized sphingolipid biosynthetic pathways are potential targets for the development of anti- G. lamblia agents.Keywords
This publication has 41 references indexed in Scilit:
- Effect of chronic Giardia lamblia infection on epithelial transport and barrier function in human duodenumGut, 2007
- De Novo Sphingolipid Synthesis Is Essential for Viability, but Not for Transport of Glycosylphosphatidylinositol-Anchored Proteins, in African TrypanosomesEukaryotic Cell, 2007
- Current Therapeutics, Their Problems, and Sulfur-Containing-Amino-Acid Metabolism as a Novel Target against Infections by “Amitochondriate” Protozoan ParasitesClinical Microbiology Reviews, 2007
- Clathrin-dependent pathways and the cytoskeleton network are involved in ceramide endocytosis by a parasitic protozoan, Giardia lambliaInternational Journal for Parasitology, 2007
- Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformansJournal of Clinical Investigation, 2006
- Giardia lamblia behavior under cytochalasins treatmentParasitology Research, 2005
- Movement of Membrane Domains and Requirement of Membrane Signaling Molecules for CytokinesisDevelopmental Cell, 2005
- Uptake of [3H]-gangliosides by an intestinal protozoan, Giardia lambliaParasitology Research, 2005
- The Role of Sphingolipids in the Maintenance of Fibroblast MorphologyJournal of Biological Chemistry, 1997
- A new medium for the axenic cultivation of Entamoeba histolytica and other EntamoebaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1978